Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Embecta Corp. - Common Stock (NQ:EMBC)

12.73 -0.02 (-0.16%)
Streaming Delayed Price Updated: 9:55 AM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Embecta Corp. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
News headline image
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
Advocacy and professional groups join global diabetes care company at Nasdaq to raise awareness of diabetes, while also commemorating the company’s 100-year legacy of serving this community 
From Embecta Corp.
Via GlobeNewswire
News headline image
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
From Embecta Corp.
Via GlobeNewswire
News headline image
Earnings Preview For Embecta ↗
 
Via Benzinga
News headline image
Thursday Is Your Last Chance To Buy Embecta Before The Dividend Payout ↗
 
Via Benzinga
News headline image
Embecta: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
embecta to Participate in Investor Events
From Embecta Corp.
Via GlobeNewswire
News headline image
EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 ↗
EMBC stock results show that Embecta beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
News headline image
Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
News headline image
embecta Announces Quarterly Cash Dividend
From Embecta Corp.
Via GlobeNewswire
News headline image
Earnings Preview: Embecta ↗
 
Via Benzinga
News headline image
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off ↗
Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The company's U.S. business has struggled with the rise of GLP-1 drugs and... 
Via Benzinga
News headline image
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
embecta to Report Fiscal Third Quarter 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
News headline image
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
From Embecta Corp.
Via GlobeNewswire
News headline image
Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs ↗
Here are three potential stocks to buy that could benefit from China tariffs amidst the turning trade winds. 
Via InvestorPlace
Topics World Trade
News headline image
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q2 2024 ↗
EMBC stock results show that Embecta beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
US Stocks Mixed; Jobless Claims Rise More Than Expected ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 9, 2024 ↗
Companies Reporting Before The Bell • TELUS (NYSE:TU) is expected to report quarterly earnings at $0.23 per share on revenue of $5.24 billion. 
Via Benzinga
News headline image
Sustaining Growth Momentum: Dentsply Sirona Continues to Excel and Reports Rising Profits ↗
As the day concludes, Dentsply Sirona (NASDAQ:XRAY) is preparing to distribute a dividend payout of $0.14 per share, resulting in an annualized dividend yield of 1.65%. This payout is exclusive to... 
Via Benzinga
News headline image
Earnings Scheduled For November 21, 2023 ↗
Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is likely to report quarterly earnings at $0.11 per share on revenue of $149.42 million. 
Via Benzinga
News headline image
7 Contrarian Stocks to Buy for the High-Stakes Gambler ↗
With limited options available as the market rotates out of risk-on assets, speculators may try their luck with contrarian stocks to buy. 
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  During Tuesday's trading, 46 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  Wednesday's session saw 43 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.